Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
44°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
OKYO Pharma Limited - Ordinary Shares
(NQ:
OKYO
)
1.520
-0.030 (-1.94%)
Streaming Delayed Price
Updated: 2:01 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about OKYO Pharma Limited - Ordinary Shares
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 14, 2023
Via
Benzinga
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 01, 2023
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 01, 2023
Via
Benzinga
NKLA Stock Alert: The $16.3 Million Reason Nikola Is Up Today
August 01, 2023
Nikola (NKLA) stock is rising higher on Tuesday after the company announced $16.3 million in new funding for its hydrogen refueling stations.
Via
InvestorPlace
SOFI Stock Alert: SoFi Drops on Analyst Downgrade
August 01, 2023
SoFi Technologies (SOFI) stock is dipping lower on Tuesday after the financial services company's shares were downgraded.
Via
InvestorPlace
Why Is OKYO Pharma (OKYO) Stock Down 19% Today?
August 01, 2023
OKYO Pharma (OKYO) stock is falling on Tuesday even after the biopharmaceutical company withdrew a public offering of its shares.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 01, 2023
Via
Benzinga
Why TETRA Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
August 01, 2023
Gainers American Superconductor Corporation (NASDAQ: AMSC) shares surged 112.1% to $21.38 in pre-market trading. AMSC is expected to report first-quarter results on Aug. 9, 2023.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
August 01, 2023
It's time for a look at the biggest pre-market stock movers as we check out the latest news worth reading on Tuesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
July 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
July 28, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 14, 2023
Via
Benzinga
Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 14, 2023
Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 14, 2023
It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?
May 30, 2023
The Japanese healthcare company Astellas Pharma, Inc. (OTC: ALPMF) recently announced its acquisition of the biopharmaceutical company Iveric Bio
Via
Benzinga
Phase 2 Trials Begin For Promising New Dry Eye Disease Treatment From OKYO Pharma
May 12, 2023
Dr. Gary S. Jacob, CEO of OKYO Pharma (NASDAQ: OKYO), was recently a guest on Benzinga’s All Access.
Via
Benzinga
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 10, 2023
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday.
Via
Benzinga
Why ClearOne Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket
May 09, 2023
Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) gained 74.2% to $0.2701 in pre-market trading after gaining around 7% on Monday.
Via
Benzinga
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 08, 2023
Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China.
Via
Benzinga
OKYO Pharma Reports First Patient Visit For Phase 2 Trial Of OK-101, To Fulfill One Of The Two Phase 3 Studies Required For FDA Approval If Successful
May 03, 2023
OKYO Pharma Limited (LSE: OKYO) (NASDAQ: OKYO) announced that the first patient has been screened for its phase 2, multicenter, randomized, double-blinded, placebo-controlled trial, evaluating the...
Via
Benzinga
OKYO Pharma Activates First Clinical Trial Site For Phase 2 Study Of OK-101 To Treat Dry Eye Disease
April 26, 2023
OKYO Pharma Limited (LSE: OKYO) (NASDAQ: OKYO) announced the activation of the first clinical trial site in the U.S. for its phase 2, multi-center, randomized, double-blinded, placebo-controlled trial,...
Via
Benzinga
OKYO Pharma Management Takes Company Stock In Private Placement Instead Of Deferred Pay
April 18, 2023
Drug development can be notoriously slow, and it can take some companies 10 years or more to pass through all the trials and tests required by the Food and Drug Administration (FDA).
Via
Benzinga
OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4
March 28, 2023
OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4
Via
News Direct
OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4
March 28, 2023
Drug development isn’t known for being fast-paced, and developing any new drug is generally a long process. However, OKYO Pharma Ltd. (NASDAQ: OKYO) is moving quickly to develop its eye treatment drug,...
Via
Benzinga
OKYO Pharma's Trial Treating Subjects With DED Gets Listed On ClinicalTrials.gov
March 17, 2023
OKYO Pharma Limited (LSE: OKYO) (NASDAQ: OKYO) announced that its planned trial evaluating the efficacy and safety of OK-101 in subjects with DED has been posted on the ClinicalTrials.gov public...
Via
Benzinga
Why Is Okyo Pharma (OKYO) Stock Up 13% Today?
March 16, 2023
Okyo Pharma (OKYO) stock is on the rise Thursday as investors react to news about its Phase 2 clinical trial of DED treatment OK-101.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.